Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A

Erscheinungsjahr 2025
ISBN: 978-0-443-34529-6
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm

Identification of Circulating Biomarkers for Diagnosis and Response to Therapies in Cancer Patients Part A delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. The book covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care, ultimately aiming to enhance patient outcomes and precision medicine strategies.

Autoren/Hrsg.

Weitere Mitwirkende

Spada, Sheila

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Entwicklungsbiologie
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

Preface Sheila Spada and Lorenzo Galluzzi 1. Circulating biomarkers for diagnosis and response to therapies in cancer patients Natália Marcéli Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva, Laura Otto Walter, Maria Cláudia Santos-Silva, and Manas Ranjan Gartia 2. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients Ronan W. Hsieh, Lynn K. Symonds, Jason Siu, and Stacey A. Cohen 3. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra 4. Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer Sabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha, M. Mujeeburahiman, and Chandrahas Koumar Ratnacaram 5. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma Queenie Fernandes, Abdul W. Ansari, Karama Makni-Maalej, Maysaloun Merhi, Said Dermime, Aamir Ahmad, and Shahab Uddin 6. Nectin-4: A promising prognostic marker and therapeutic target in cancer Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, Zahwa Mariyam, Queenie Fernandes, Mohsin Maqbool, Omar M. Khan, Ajaz A. Bhat, and Shahab Uddi

Über Autor(innen)

Spada, Sheila
Sheila Spada is at Weill Cornell Medical College, NY, USA